Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMDL (BB: AMDDD) -- Ignore unavailable to you. Want to Upgrade?

To: JSB who wrote (1)	10/17/1998 10:41:00 AM
From: bigbuk	Respond to of 6

stkpker1; You got my vote on that. BB should soon turn around. You can't beat them much beyond death now can you? Regards bigbuk

To: JSB who wrote (1)	10/19/1998 8:23:00 AM
From: EasyWay	Read Replies (1) \| Respond to of 6

I am hearing that talks to obtain needed financing are going well. If they can get $1 million they will be back on their feet and ready to make a go of this thing. $5 million would be enough to do all that needs to be done including US clinical trials for DR-70 which is what we have been looking for all along. Since the reverse split is behind us, the float would grow to 6 to 8 million at todays price levels (based on obtaining $5 million) which should make this stock grow very quickly when the approval process is done. With worldwide sales of both DR-70 and their ulcer kit we should see $2 to $3 per share in earnings. If the stock sells at a 20:1 PE ratio that puts your existing stock at the $40 to $60 price level. Not bad! Easy:)